Plasma cell leukemia (PCL) is a rare disease that may present de novoor secondary to plasma cell myeloma. Advanced disease and extramedullary involvement are common clinical features at presentation.

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Multiple myeloma is a rare blood cancer of the plasma cells in bone marrow -- the soft, spongy interior of bone where ...

Longtime 95.5 WSB radio host Scott Slade has announced he has been diagnosed with multiple myeloma, a type of blood cancer ...

DelveInsight's "CARVYKTI Market Size, Forecast, and Market Insight Report" highlights the details around CARVYKTI, a ...

The most effective means of improving host defense in myeloma may be reduction of the number of neoplastic plasma cells and levels of anomalous globulins in the serum with chemotherapy.

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.

SkylineDx has published a new study marking a “significant advancement” in the understanding and identification of high-risk (HR) multiple myeloma (MM) patients. The Dutch company’s prospective ...

Radio EMFM 104.7 is hosting its second ‘My Greatest Walk’ for Myeloma Australia on Sunday, March 30.

Oncologists are increasingly favoring CAR T-cell therapy’s early-line use in relapsed/refractory multiple myeloma despite ...

Multiple myeloma is a type of cancer characterized by the uncontrolled proliferation of clonal plasma cells, which leads to ...

Multiple myeloma is a rare blood cancer of the plasma cells in bone marrow -- the soft, spongy interior of bone where all blood cells are produced. Plasma cells are a type of white blood cell that ...